Risk of Product Defects and Recalls
First written in FY2016. 2 of 5 entries say "Reframed", first in FY2020. Latest entry: FY2023.
The whole theme swung hardest in 2026: 11 of 57 companies on the "Worse" side.
- FY2023ReframedAnnual report
「The bottling plant in Indonesia also faces risks of product defects and liability, as does the water-ionizer business. We are implementing equipment management and employee training with the aim of operating quality controls at Japanese standards.」
In addition to the existing water-ionizer and cell-banking businesses, the company explicitly identifies product-defect risks at its Indonesian bottling plant and its quality-control response. - FY2022MitigatedAnnual report
「Electrolyzed hydrogen water ionizers are manufactured at our own plant in accordance with the QMS Ministerial Ordinance※1 and certified to ISO13485 and ISO9001※2. Safety is our highest priority, and we work to maintain and improve quality. At StemCell Institute, we undergo inspections by third-party certification bodies under global quality standards such as AABB※3 and ISO9001, and work to maintain and improve quality and facility operations.」
In addition to quality control for water ionizers, the company is implementing specific quality-maintenance measures at its cell bank by using third-party certifications and inspections, including AABB and ISO9001. - FY2020ReframedAnnual report
「Electrolyzed hydrogen water ionizers are manufactured at our own plant in accordance with GMP standards and certified to ISO13485 and ISO9001. Safety is our highest priority, and we work to maintain and improve quality. In the umbilical cord blood banking business within our healthcare-related operations, the quality of cells may be compromised if supplies of reagents required for cell separation and processing, or liquid nitrogen used to cool tanks for long-term storage, are disrupted, or if equipment fails to operate normally.」
In addition to product-defect and recall risks, the company explicitly identifies risks to maintaining cord blood quality arising from disruptions in reagent and liquid nitrogen supplies and equipment shutdowns, broadening the scope of quality control. - FY2017RestatedAnnual report
「Our group makes every effort to ensure product safety as its highest priority, from development and manufacturing through sales and services. We have insurance covering product liability, but some risks are not covered. In addition, substantial costs could arise if, for example, we conduct a large-scale recall to protect customer safety, which could adversely affect our group's business performance and financial condition.」
While prioritizing product safety and maintaining insurance coverage, the company reiterates the risks of uncovered liabilities and large-scale recalls. - FY2016First statedAnnual report
「Our group makes every effort to ensure product safety as its highest priority, from development and manufacturing through sales and services. We have insurance covering product liability, but some risks are not covered. In addition, substantial costs could arise if, for example, we conduct a large-scale recall to protect customer safety, which could adversely affect our group's business performance and financial condition.」
While prioritizing product safety and maintaining insurance coverage, the company identifies uncovered risks and costs arising from large-scale recalls as risks.